The largest database of trusted experimental protocols

36 protocols using p450 glo assay

1

CYP Enzyme Activity Measurement

Check if the same lab product or an alternative is used in the 5 most similar protocols
For CYP activity measurement, “P450-Glo™ Assays” (Promega, Madison, Wisconsin, USA) were used. CYP1A2 activity was detected by Methoxy-Luciferin (Luciferin-ME) turnover (V8772), CYP2B6 was detected by Dimethoxybutyl-Luciferin (Luciferin-2B6) turnover (V8321) and CYP3A4 was detected by Luciferin isopropyl acetal (Luciferin-IPA) turnover (V9001). The reaction was performed according to the Promega “P450-Glo™ Assays” protocol except the CYP reaction time was prolonged to 1 h unless otherwise noted. The reaction temperature was set at 37 °C. The NADPH Regeneration System (V9510) was used for the supply of NADPH during the assay. Three control approaches were performed, one with buffer control, one designed as no template control and one control, using human liver cell microsomes (Gibco™ Human Microsomes, 50 Donors) (Thermo Fisher Scientific, Waltham, Massachusetts, USA) as positive control. Human microsomes were tested at a final concentration of 0.4 mg/mL. If not otherwise noted 5 µL of the microsomal fraction of the cell-free reaction were applied as samples to the activity assay. For response condition adjustments, CYP activities were usually expressed as percentage of the highest CYP activity during the assay. For CYP activity quantification, a standard curve was prepared using beetle luciferin (Promega, Madison, Wisconsin, USA) according to the protocol.
+ Open protocol
+ Expand
2

Colon and Liver Microsome Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microsomes were isolated from colon and liver tissues using the Endoplasmic Reticulum Isolation Kit (Sigma-Aldrich, St. Louis, MO). Using the P450-Glo assay (Promega, Madison, WI) isolated microsomes were then used to assay for CYP1A1 and 1B1 enzyme activity in the liver and colon. For analysis of GST activity, isolated proteins from the colon and liver were used and assayed using the Glutathione S-Transferase Assay Kit (Cayman Chemical, Ann Arbor, MI).
+ Open protocol
+ Expand
3

CYP3A4 Activity Measurement via Luminescence

Check if the same lab product or an alternative is used in the 5 most similar protocols
CYP3A4 enzymatic activity was measured by the P450-Glo Assay (Promega) luminescent method as manufacturer’s protocol.
+ Open protocol
+ Expand
4

Measuring CYP2C9 and CYP3A4 Activities

Check if the same lab product or an alternative is used in the 5 most similar protocols
CYP2C9 and CYP3A4 enzyme activities were assessed by P450‐Glo assay (Promega, Madison, WI, USA), according to the manufacturer's instructions. Differentiated cells were treated with or without 25 μM rifampicin (Sigma‐Aldrich), a PXR agonist, for 72 hrs, and the media were changed on the cells every day. The cells were incubated at 37°C in fresh medium with Luciferin‐H for 4 hrs or Luciferin‐IPA for 60 min. separately. After the incubation, 50 μl of medium was transferred to a 96‐well plate and mixed with 50 μl of luciferin detection reagent to initiate the luminescent reaction. After 60 min. of incubation at 37°C, the luminescence was measured with a luminometer (Envision2104‐0010, Waltham, MA, USA).
+ Open protocol
+ Expand
5

Isolation and Enzymatic Assays of Colon and Liver Microsomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microsomes were isolated from colon and liver tissues using the Endoplasmic Reticulum Isolation Kit (Sigma-Aldrich, St. Louis, MO). The isolated microsomes were then assayed for CYP1A1 and 1B1 enzyme activity in the liver and colon using the P450-Glo assay (Promega, Madison, WI). For analysis of GST activity, isolated proteins from the colon and liver were assayed using the Glutathione S-Transferase Assay Kit (Cayman Chemical, Ann Arbor, MI).
+ Open protocol
+ Expand
6

Assessing CYP2C19 Inhibition Potential

Check if the same lab product or an alternative is used in the 5 most similar protocols
The inhibition of CYP2C19 activity was determined using the P450-Glo assay (Promega) according to the manufacturer’s instructions. Briefly, purified recombinant human CYP2C19 isozyme was purchased from Promega. The enzyme was incubated with 100 µg/mL of each compound for 30 minutes, followed by the addition of the specific luminescent substrate and the NADPH regenerating system (containing NADP+, glucose-6-phosphate, MgCl2, and glucose-6-phosphate dehydrogenase) provided with the kit. The reaction mixture was incubated at room temperature for 30 minutes followed by the addition of the luciferin detection reagent. The luminescence was measured using a luminometer after incubation with the reagent for 20 minutes.
+ Open protocol
+ Expand
7

Cytochrome P450 Enzyme Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
CYP measurement was performed on day eight following the formation of LBs using the P450-Glo™ assay (Promega), according to the manufacturer’s instructions. Rifampicin with or without ketoconazole or sulfaphenazole was loaded eight hours before the collection of medium for analysis.
+ Open protocol
+ Expand
8

Hepatic Microsome Isolation and CYP3A4 Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microsome preparations were obtained from hepatic tissues using the Biovision Microsome Isolation Kit (product #K249). Mice (n = 9 SRS and n = 6 control) were perfused intracardially with PBS, the livers dissected and homogenized using the reagents provided by the vendor. After centrifugation, the microsomal pellets were suspended in storage buffer and kept at −80°C. Protein concentration was determined using a Thermo Scientific NanoDrop 2000 (absorbance at 280nm). Cyp3a4 activity was quantified using a Promega P450-Glo assay (#V9001). Briefly, microsomal fractions (96-well plate) were combined with a selective substrate (Luciferin-IPA) for 10 min at 37°C. The enzymatic reaction was initiated using a NADPH regenerating system supplied by the vendor. A luciferin detection reagent was added and the luminescent signal quantified (Lifesciences Tecan Infinite 200; integration time of 1000ms/well). The standard curve was determined using D-Luciferin (0.016, 0.08, 0.4, 2 and 10 μM).
+ Open protocol
+ Expand
9

Quantifying Cytochrome P450 Activities

Check if the same lab product or an alternative is used in the 5 most similar protocols
CYP 3A and CYP 1A2 activity were measured on HLCs at day 18 by using the P450-Glo™ assay (Promega). CYP 3A (1:20) and CYP 1A2 (1:50) substrates were diluted in hepatocyte maturation medium and added to the HLCs for 5 37 °C in 5% (v/v) CO2, plain medium with substrate was incubated in parallel to subtract background. After incubation, 50 μL of supernatant was collected and mixed with 50 μL of luciferin detection reagent in a white 96-well plate at room temperature in the dark for 20 min. Luminescence was measured using a multiplex plate reader (GloMax Explorer, Promega) and normalized per mg of protein (RLU/ml/mg) quantified by BCA assay.
+ Open protocol
+ Expand
10

Quantifying CYP activity via P450-Glo assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Measurement of the activity of all four CYPs was conducted using the P450-Glo assay (Promega, Japan), according to the manufacturer’s instructions. Briefly, cells were seeded in a 96-well plate at a density of 1×104 cells/well. Twenty-four hours later, test compounds and the luminescent substrate included in the kit were added into the culture media. Following 1 hour of incubation, the detection reagent was added, and the luminescence generated by the metabolic substrate within the culture media was measured using an Infinite F500 plate reader (Wako). The inhibitor test conditions utilized in this study are listed in the results.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!